Procaps Group, S.A Long Term Debt 2020-2023 | PROCF
Procaps Group, S.A long term debt from 2020 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Procaps Group, S.A Annual Long Term Debt (Millions of US $) |
2022 |
$28 |
2021 |
$179 |
2020 |
$352 |
2020 |
$ |
2019 |
$ |
2019 |
$ |
2018 |
$ |
Procaps Group, S.A Quarterly Long Term Debt (Millions of US $) |
2023-09-30 |
$221 |
2023-06-30 |
$170 |
2023-03-31 |
$150 |
2022-12-31 |
$28 |
2022-09-30 |
$171 |
2022-06-30 |
$182 |
2022-03-31 |
$169 |
2021-12-31 |
$179 |
2021-09-30 |
$113 |
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
$352 |
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|